http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2011009301-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5723838cfc3775d34156e4604ba8d4d7
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2011-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a6f33792edba51217af955da6d2a306
publicationDate 2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2011009301-A
titleOfInvention COMPOSITIONS AND METHODS TO TREAT MYELODISPLASIC SYNDROME.
abstract This invention relates to treatment regimens for treating myelodysplastic syndrome.
priorityDate 2011-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411675801
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426070332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492295
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID451668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453943498
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25063260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5310939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216326

Total number of triples: 23.